DGAP-News: Proteo, Inc. / Proteo Biotech AG: Major advances in the elafin development program for lung diseases – NIH supports research on Elafin with a $10.8 million grant
DGAP-News: Proteo Biotech AG / Schlagwort(e): Research Update/Studie
Proteo, Inc. / Proteo Biotech AG: Major advances in the elafin
development program for lung diseases – NIH supports research on
Elafin with a $10.8 million grant
06.12.2011 / 11:44
———————————————————————
Proteo, Inc. / Proteo Biotech AG:
Major advances in the elafin development program for lung diseases – NIH
supports research on Elafin with a $10.8 million grant
Irvine, CA –
